{"id":3966,"date":"2020-08-26T09:17:53","date_gmt":"2020-08-26T09:17:53","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/s-hydroxybutyrate-ready-to-use-reagent\/"},"modified":"2021-01-08T11:27:09","modified_gmt":"2021-01-08T11:27:09","slug":"s-hydroxybutyrate-ready-to-use-reagent","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/s-hydroxybutyrate-ready-to-use-reagent\/","title":{"rendered":"\u00df-Hydroxybutyrate ready-to-use reagent"},"content":{"rendered":"
DiaSys offers an improved, liquid-stable and ready-to-use reagent for common clinical chemistry analysers. For the determination of \u00df-hydroxybutyrate (\u00df-HBUT) serum and plasma samples can be used. \u00df-HBUT is an important marker to detect diabetic ketoacidosis (DKA), a potentially life-threatening complication in diabetes mellitus, which can lead to coma or even death. The new \u00df-Hydroxybutyrate 21 FS offers a wide measuring range which ensures few sample repeats and therefore is time- and cost-saving. Interferences to endogenous and exogenous substances were minimized and calibration and on-board stability were prolonged to 12 weeks. The new \u00df-Hydroxybutyrate 21 FS is robust and provides accurate and highly reproducible results.<\/p>\n
\nSupplier:<\/strong> DiaSys Diagnostic Systems GmbH
\nWebsite:<\/strong> <\/a><\/p>\n